#London #United Kingdom #Innovation Conference #AI Discovery #Sequential

Introduction

The world of personal care is on the brink of a significant transformation, thanks in large part to advancements in artificial intelligence and clinical validation methods. On December 3, 2026, Sequential, a leader in personal care testing, will hold its inaugural conference titled "The Future of Next-Generation Ingredients & Validation" in London, specifically in the Attenborough Room at The Mills Fabrica.

Conference Overview

This groundbreaking event aims to unite industry professionals, fostering discussions about the future of ingredient development in beauty, personal care, and biotechnology. The one-day forum will gather esteemed professionals in research and development, innovation, and scientific leadership from across the globe. Dr. Oliver Worsley, CEO and Co-founder of Sequential, emphasizes the growing demand from the market for new proof standards regarding ingredient efficacy, heavily influenced by AI and multi-omics research.

AI and Multi-Omics: A New Frontier

AI and multi-omics represent a new frontier in ingredient sourcing, allowing for more personalized and effective products. AI technology helps in analyzing vast amounts of data related to ingredients and consumer preferences quickly, resulting in significant advancements in product formulation. The use of multi-omics approaches—which integrate genetic, proteomic, and metabolomic data—provides a deeper understanding of how ingredients work at a cellular level, paving the way for innovative developments in personal care products.

Key Sessions and Notable Speakers

The conference promises to offer sharp and insightful sessions focusing on real innovation and actionable market cases, ensuring that attendees gain invaluable peer-to-peer knowledge. Confirmed speakers for the day include:

• - Lieve Declercq, Proya Companies – delivering the keynote address
• - Dr. Amir Jassim, formerly of the University of Cambridge and Cancer Research UK
• - Dr. Martin Pagac, dsm-firmenich
• - Christina Patane, Medik8
• - John Milligan, The Honey Pot Company
• - Veronika Oudova, S-Biomedic (Beiersdorf)
• - Albert Dashi, PhD, Chief Science Officer and Co-founder of Sequential

Each speaker will provide insights into different aspects of next-gen ingredients—from AI discoveries to bioengineered ingredients targeting longevity and healthy aging, alongside discussions about the necessary clinical validation processes.

Importance of Clinical Validation

As the industry shifts towards science-driven standards, clinical validation becomes crucial in gaining consumer trust. Attendees will explore how various research methodologies are playing a vital role in evidence-based product development. Sessions will cover the latest trends in consumer demand for sustainable, effective, and scientifically supported ingredients.

Networking Opportunities

The conference will also serve as a pivotal networking opportunity where industry leaders and innovators can connect. This interaction will allow for an exchange of ideas, brainstorming potential collaborations, and establishing long-lasting relationships within the field, essential for driving the personal care industry forward.

Conclusion

The Future of Next-Generation Ingredients & Validation conference promises an engaging program that reflects the evolving dynamics of personal care. It aims to position itself as a forum for discussing the tools and technologies reshaping the industry and setting trends for the future. Register today at Sequential's event page to ensure a place at this vital industry event.